European Journal of Cancer

Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only − the SIOP 93–01 and 2001 protocols

European Journal of Cancer ◽

10.1016/j.ejca.2021.12.014 ◽

2022 ◽

Vol 163 ◽

pp. 88-97

Author(s):

Alissa Groenendijk ◽

Harm van Tinteren ◽

Yilin Jiang ◽

Ronald R. de Krijger ◽

Gordan M. Vujanic ◽

...

Keyword(s):

Actinomycin D ◽

Intermediate Risk ◽

Wilms Tumour

Download Full-text

Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment

European Journal of Cancer ◽

10.1016/j.ejca.2021.12.023 ◽

2022 ◽

Vol 163 ◽

pp. 44-54

Author(s):

Marika Sculco ◽

Marta La Vecchia ◽

Anna Aspesi ◽

Giulia Pinton ◽

Michela G. Clavenna ◽

...

Keyword(s):

Dna Repair ◽

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Dna Repair Genes ◽

Germline Variants ◽

Tailored Treatment ◽

Repair Genes

Download Full-text

Next-generation sequencing reveals tumour origin in a patient with rare metachronous colonic metastasis from pancreatic cancer

European Journal of Cancer ◽

10.1016/j.ejca.2021.12.019 ◽

2022 ◽

Vol 163 ◽

pp. 77-78

Author(s):

Jing Zhu ◽

Dong-Sheng Chen ◽

Ya-Jun Ma ◽

Mei-Li Chen ◽

Yan Yang

Keyword(s):

Pancreatic Cancer ◽

Next Generation Sequencing ◽

Next Generation ◽

Colonic Metastasis ◽

Generation Sequencing ◽

Tumour Origin

Download Full-text

Evolution of low HER2 expression between early and advanced-stage breast cancer

European Journal of Cancer ◽

10.1016/j.ejca.2021.12.022 ◽

2022 ◽

Vol 163 ◽

pp. 35-43

Author(s):

Paolo Tarantino ◽

Sara Gandini ◽

Eleonora Nicolò ◽

Pamela Trillo ◽

Federica Giugliano ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Stage ◽

Her2 Expression

Download Full-text

Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma

European Journal of Cancer ◽

10.1016/j.ejca.2021.12.017 ◽

2022 ◽

Vol 163 ◽

pp. 26-34

Author(s):

Sai-Lan Liu ◽

Xue-Song Sun ◽

Qiu-Yan Chen ◽

Ze-Xian Liu ◽

Li-Juan Bian ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Induction Chemotherapy ◽

Distant Metastasis ◽

Gene Signature ◽

Development And Validation

Download Full-text

Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus

European Journal of Cancer ◽

10.1016/j.ejca.2021.12.015 ◽

2022 ◽

Vol 163 ◽

pp. 79-87

Author(s):

Victoria Atkinson ◽

Caroline Robert ◽

Jean J. Grob ◽

Helen Gogas ◽

Caroline Dutriaux ◽

...

Keyword(s):

Adverse Event ◽

Event Management ◽

Management Algorithm ◽

Adverse Event Management

Download Full-text

Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years

European Journal of Cancer ◽

10.1016/j.ejca.2021.12.007 ◽

2022 ◽

Vol 163 ◽

pp. 1-15

Author(s):

Demetris Papamichael ◽

Guilherme S. Lopes ◽

Curt L. Olswold ◽

Jean-Yves Douillard ◽

Richard A. Adams ◽

...

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Metastatic Colorectal Cancer ◽

Growth Factor Receptor ◽

Wild Type ◽

Epidermal Growth

Download Full-text

Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma

European Journal of Cancer ◽

10.1016/j.ejca.2021.12.012 ◽

2022 ◽

Vol 163 ◽

pp. 55-65

Author(s):

Guru P. Sonpavde ◽

Cora N. Sternberg ◽

Yohann Loriot ◽

Aurelien Marabelle ◽

Jae Lyun Lee ◽

...

Keyword(s):

Urinary Tract ◽

Fixed Dose ◽

Open Label ◽

Multicenter Phase ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases

European Journal of Cancer ◽

10.1016/j.ejca.2021.12.013 ◽

2022 ◽

Vol 163 ◽

pp. 66-76

Author(s):

Yuma Wada ◽

Mitsuo Shimada ◽

Yuji Morine ◽

Tetsuya Ikemoto ◽

Yu Saito ◽

...

Keyword(s):

Liver Metastases ◽

Colorectal Liver Metastases ◽

Cancer Recurrence ◽

Transcriptomic Signature

Download Full-text

Atezolizumab-induced autoimmune haemolytic anaemia caused by drug-independent antibodies

European Journal of Cancer ◽

10.1016/j.ejca.2021.11.031 ◽

2022 ◽

Vol 162 ◽

pp. 158-160

Author(s):

Bradley S. Chambers ◽

David Ward ◽

Robert Webster ◽

Valerie Tunnard ◽

Quentin A. Hill

Keyword(s):

Haemolytic Anaemia ◽

Autoimmune Haemolytic Anaemia

Download Full-text

European Journal of Cancer
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only − the SIOP 93–01 and 2001 protocols

Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment

Next-generation sequencing reveals tumour origin in a patient with rare metachronous colonic metastasis from pancreatic cancer

Evolution of low HER2 expression between early and advanced-stage breast cancer

Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma

Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus

Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years

Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma

A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases

Atezolizumab-induced autoimmune haemolytic anaemia caused by drug-independent antibodies

Export Citation Format

European Journal of CancerLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only − the SIOP 93–01 and 2001 protocols

Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment

Next-generation sequencing reveals tumour origin in a patient with rare metachronous colonic metastasis from pancreatic cancer

Evolution of low HER2 expression between early and advanced-stage breast cancer

Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma

Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus

Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years

Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma

A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases

Atezolizumab-induced autoimmune haemolytic anaemia caused by drug-independent antibodies

European Journal of Cancer
Latest Publications